Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for agitation in dementia
ISRCTN17411897Phase 3Completed
- Sponsor
- University of Sussex
- Start
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Dementia comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Change in agitation at 12 weeks. Started Sep 2016; status: completed.
02
Drugs
mirtazapine
03
Conditions
Dementia
Beyond the preview
Go deeper on ISRCTN17411897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17411897.